Skip to main content

Table 4 Number (%) of treatment-related ocular adverse events (N = 590)

From: First-line latanoprost therapy in ocular hypertension or open-angle glaucoma patients: a 3-month efficacy analysis stratified by initial intraocular pressure

 

Baseline Intraocular Pressure

Subjects with:

20 to <24 mmHg

N = 262

≥ 24 mmHg

N = 328

Hyperemia

28 (10.7)

28 (8.5)

Eye pain

8 (3.1)

11 (3.4)

Blepharitis

3 (1.2)

1 (0.3)

Eyelid pruritis

3 (1.2)

1 (0.3)

Eye abnormality NOS

2 (0.8)

2 (0.6)

Keratitis

2 (0.8)

2 (0.6)

Eyelid edema

0

3 (0.9)

Photophobia

1 (0.4)

0

Vision abnormal NOS

0

1 (0.3)

Xerophthalmia

0

1 (0.3)

  1. NOS = not otherwise specified.